PTH2R is related to cell proliferation and migration in ovarian cancer: a multi-omics analysis of bioinformatics and

Wang Xiaowei1, Lu Tong2, Qu Yanjun1

  • 1Department of Ultrasnography in Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Abstract

Insights

Parathyroid hormone receptor 2 (PTH2R) is highly expressed in ovarian cancer, promoting tumor cell proliferation, invasion, and metastasis. Inhibiting PTH2R shows potential for new ovarian cancer treatments and diagnostic markers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Ovarian cancer poses a significant threat to women's health.
  • Effective molecular markers for ovarian cancer diagnosis and treatment are lacking.

Purpose of the Study:

  • To identify novel molecular markers for ovarian cancer.
  • To investigate the role of specific genes in ovarian cancer development.

Main Methods:

  • Bioinformatic analysis of GEO and TCGA databases to identify key genes.
  • Experimental validation using qPCR, Western Blot (WB), CCK-8, and Transwell assays.

Main Results:

  • The PTH2R gene was found to be highly expressed in ovarian tumors.
  • PTH2R gene expression correlated with increased proliferation, invasion, and metastasis of ovarian cancer cells.

Conclusions:

  • Downregulating PTH2R expression inhibits ovarian tumor cell proliferation, invasion, and migration.
  • PTH2R presents potential as a novel molecular marker for ovarian cancer.